CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE
about
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsChallenges and opportunities for the implementation of virological testing in resource-limited settingsThe clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefitAbsence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, BrazilCause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyCD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaFactors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013.Can we trust the guidelines? Comparison between the data presented and the recommendations of the International Antiviral Society-USA PanelThe prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in JapanHIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Tryptophan catabolism and immune activation in primary and chronic HIV infectionResidual immune dysregulation syndrome in treated HIV infection.Is CD4 monitoring needed among ugandan clients achieving a virologic and immunologic response to treatment?HIV treatment outcomes among people who inject drugs in Victoria, Australia.Assessment of duration of staying free from acquiring rehappening opportunistic infections among pre-ART people living with HIV/AIDS between 2008 and 2013.Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection.CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project PhidisaEarly but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of DissentAdvanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study.Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort StudyThe MANGUA Project: A Population-Based HIV Cohort in Guatemala.Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionThe interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.Bloodstream infections in HIV-infected patients.Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypesHuman immunodeficiency virus and liver disease forum 2012.Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.HIV and the heart: the impact of antiretroviral therapy: a global perspective.No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.Immunosenescence and hurdles in the clinical management of older HIV-patients.
P2860
Q26740117-B0351E22-20A9-457E-A01E-3EA6A657CF0EQ27026923-E881DF1E-59C3-4598-978F-78750C0DC03FQ28535156-55723131-A5BE-4D32-983B-F7B9536B4B6CQ28540014-F500927F-8705-4CCC-83DC-34B229672F33Q28553516-755DEA7C-547F-4357-84E4-54511AD8AC48Q28703565-27E9B7DC-1675-431D-811F-97039BCE9725Q30378028-34BF32E3-756E-4CC5-BCBD-A3725B8726E6Q30869836-C173B5E8-27EF-4ABF-B0B8-537668B2AC67Q33593774-A7340B96-7879-4C47-BA36-FCF40C557816Q33618542-133FB679-8FA8-4855-9827-D8962FD3F3CCQ33697163-2956AF18-39F0-43A0-922B-A9116259D4BDQ34020121-18D25D45-E6DD-41DD-B03B-14E06F1D8420Q34488004-C4A21345-0EE3-4C53-A7FE-C54DAC7E5A70Q34984426-28B5937A-17FE-431E-88FA-376748A9AD16Q35037628-D9EE39CC-FDB8-4E69-B528-B2C9AAE628FDQ35082803-454A76B8-600D-405A-8911-E87DA6B4A4EDQ35119369-B7EB6E95-D6FA-44F6-A826-5E36F04D6EA2Q35345807-D7B8A055-A585-4F7B-B857-718705202BB5Q35630665-A835C39F-FE01-4721-B851-7589DEB8BD63Q35782774-8D1C2885-2868-45A4-A067-BA5BE863A3B7Q35856740-82759E3C-2C14-4E05-A1B8-3A862664600FQ35925705-A09EC35D-BCA8-417B-BDA6-0864E834D185Q35993151-F871E96F-83B7-4263-84D3-E9F43BF20F58Q36068935-D18BB0E7-130D-45AC-A363-431E0D0A53B4Q36074672-6339E1A6-6695-4F8F-8281-F20F4C4FD69EQ36581887-E72D6482-B519-4E15-974C-78F3AA7E25C9Q36763062-F94CCF9F-5362-4816-AB29-2EA151BBEB0EQ36783202-8952D73A-7735-4161-ABCB-5F8EABB7E93BQ36913307-5C1AD5AC-9AB7-4AB5-AF0B-9A9FB3C3EF9CQ37244544-558BFAA3-1349-402B-AF50-9528605AD333Q37361082-960E61E6-97E5-4B4E-873C-88E40137A7F7Q37499490-BF2B8093-E48F-4349-8C9B-F33982CF98BBQ38152708-FB242D52-2596-46AB-AC0D-9DEB6D698FC8Q38427594-3A3214A7-B90A-444D-86A8-5C0A39E56842Q38619193-D4733137-4B16-4076-8E80-42E4185EA0A9Q38686953-527FB2BA-1938-4A11-8AF0-B57D7D88FF88Q38855036-98FE7564-0415-4116-9476-F23929563AF5Q38873796-EB205B24-6F84-4EEF-A36C-DC6B4CA3EF6CQ38917930-2A417A49-CC6D-4F0B-93EB-88D5E6BA3238Q39170367-98D0AE69-FD9B-401D-A18F-460A98523C8A
P2860
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@ast
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@en
type
label
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@ast
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@en
prefLabel
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@ast
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@en
P2093
P2860
P50
P1433
P1476
CD4 cell count and the risk of ...... dinal cohort study from COHERE
@en
P2093
Antonella Castagna
Brian Gazzard
Francois Raffi
Félix Gutierrez
Heiner Bucher
Jesper Grarup
Jesper Kjaer
Josefa Muñoz
José M Miro
P2860
P304
P356
10.1371/JOURNAL.PMED.1001194
P407
P577
2012-03-20T00:00:00Z